Loading candles…
Lotus Eye Hospital and Institute Ltd was incorporated in 1990 and operates within the healthcare and ophthalmology industries. The company provides ophthalmology and related eye care services through its network of hospitals and clinics, primarily located in Southern India. Its business segments focus on ophthalmology services, offering both basic and advanced eye care treatments. The hospital operates using specialized equipment and a panel of expert doctors within an organized structure aimed at delivering high-quality treatment. Lotus Eye Hospital and Institute Ltd does not have listed subsidiaries, founders, or key management details publicly noted, nor is it listed on any stock exchange.
This page is a live market overview for LOTUS EYE HOSP & INST L (LOTUSEYE) on the NSE. As a listed security, LOTUS EYE HOSP & INST L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LOTUSEYE before placing trades on tick2trade.
As of the latest feed, LOTUSEYE last traded at ₹115.2 on NSE, up ₹0.23 (0.20%) from the previous close of ₹114.97. Today's session range is ₹113.11 – ₹116.59, against a 52-week band of ₹97.59 – ₹147. Traded volume today stands at 5.31K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for LOTUSEYE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LOTUSEYE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for LOTUS EYE HOSP & INST L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LOTUSEYE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LOTUSEYE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 10 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 26 May 2026 |
| Voluntary Delisting | To consider the proposal for voluntary delisting of the Company's equity shares from NSE | 17 Mar 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 12 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.